HORMONAL REGULATION OF MALE REPRODUCTION
Male reproductive function relies on a finely tuned endocrine system that regulates sperm production, sexual development and androgen-dependent physiological processes. This system is governed by the hypothalamic–pituitary–gonadal (HPG) axis, which integrates neural and hormonal signals to control testicular function. The hormones of this axis, GnRH, FSH, LH and testosterone, work in concert with local paracrine factors in the testes to maintain continuous spermatogenesis and stable androgen levels.
What You Need to Know
Male reproductive function is regulated by the hypothalamic–pituitary–gonadal axis, a tightly coordinated hormonal system that controls testosterone production and spermatogenesis. Regulation begins in the hypothalamus, where gonadotropin-releasing hormone is secreted in a pulsatile pattern. This pulsatility is essential, as continuous GnRH exposure would suppress rather than stimulate pituitary activity. GnRH acts on the anterior pituitary to drive release of luteinising hormone and follicle-stimulating hormone, which then act directly on the testes.
Within the testes, luteinising hormone stimulates Leydig cells to synthesise testosterone, while follicle-stimulating hormone acts on Sertoli cells within the seminiferous tubules. Sertoli cells provide metabolic and structural support for developing germ cells and coordinate the progression of spermatogenesis. They also produce inhibin B, a peptide hormone that reflects spermatogenic activity and contributes to fine regulation of pituitary output. High intratesticular testosterone concentrations, far exceeding circulating levels, are required for normal sperm development.
Hormonal regulation is maintained through negative feedback loops that stabilise reproductive function. Key regulatory relationships include:
GnRH, which drives pituitary secretion of LH and FSH in a pulse-dependent manner
LH, stimulating Leydig cell testosterone production
FSH, supporting Sertoli cell function and spermatogenesis
Testosterone, suppressing hypothalamic GnRH and pituitary LH release
Inhibin B, selectively inhibiting pituitary FSH secretion
Testosterone exerts both local and systemic effects. Within the testes, it is essential for spermatogenesis, while systemically it mediates development and maintenance of male secondary sexual characteristics, supports libido, and maintains accessory reproductive organs. The balance between GnRH, gonadotrophins, testosterone, and inhibin B allows sperm production and androgen levels to remain stable over time, while still being responsive to physiological stress, illness, ageing, and endocrine disruption.
Beyond the Basics
GnRH Pulsatility: The Master Pacemaker
Gonadotropin-releasing hormone is secreted from the hypothalamus in discrete pulses approximately every 60 to 120 minutes. This pulsatile pattern is critical for normal male reproductive function, as both the frequency and amplitude of GnRH release determine downstream secretion of luteinising hormone and follicle-stimulating hormone from the anterior pituitary. Faster pulse frequencies tend to favour LH secretion, while slower frequencies support relatively greater FSH release.
Loss of pulsatility has profound consequences. Continuous, non-pulsatile GnRH exposure leads to downregulation of pituitary GnRH receptors, suppressing LH and FSH release and effectively silencing the entire hypothalamic–pituitary–gonadal axis. This principle is used therapeutically in conditions such as prostate cancer but also illustrates how finely tuned GnRH signalling must be to sustain testosterone production and spermatogenesis.
LH and Leydig Cells: Androgen Production
Luteinising hormone acts directly on Leydig cells within the interstitial tissue of the testes. Binding of LH to its receptor initiates steroidogenesis, converting cholesterol into testosterone through a series of enzymatic steps. Testosterone production within the testis is substantial, generating intratesticular concentrations far higher than those found in systemic circulation, a requirement for normal sperm development.
Only a small proportion of testosterone enters the bloodstream. In peripheral tissues, some testosterone is converted to dihydrotestosterone by the enzyme 5α-reductase. Dihydrotestosterone has greater androgenic potency and is particularly important in tissues such as the prostate, external genitalia, and hair follicles, where it drives growth and differentiation.
FSH and Sertoli Cells: Supporting Spermatogenesis
Follicle-stimulating hormone targets Sertoli cells lining the seminiferous tubules and plays a central role in coordinating spermatogenesis. Sertoli cells respond to FSH by regulating the metabolic and ionic environment of the tubules, supporting germ cell development and maintaining the blood–testis barrier. They also produce androgen-binding protein, which concentrates testosterone within the tubules to levels necessary for meiosis and spermiogenesis.
In addition to their supportive role, Sertoli cells act as endocrine regulators by secreting inhibin B. Inhibin B reflects spermatogenic activity and selectively suppresses FSH secretion from the anterior pituitary, allowing fine control of sperm production independent of systemic testosterone levels.
Testosterone: Local and Systemic Actions
Testosterone exerts essential effects both within the testes and throughout the body. Locally, high intratesticular testosterone concentrations support meiotic progression, spermatid maturation, and ongoing Sertoli cell function. Systemically, testosterone drives development and maintenance of male reproductive organs, sustains libido and erectile physiology, promotes muscle mass and bone density, deepens the voice through laryngeal growth, influences sebum production and hair growth, and stimulates erythropoiesis.
In circulation, most testosterone is bound to sex hormone-binding globulin or albumin, with only a small free fraction available to enter target tissues. Changes in binding protein levels can therefore alter biological androgen activity without changing total testosterone concentration.
Negative Feedback and Axis Stability
Stability of the hypothalamic–pituitary–gonadal axis depends on tightly regulated negative feedback mechanisms. Testosterone suppresses GnRH release at the hypothalamus and reduces LH secretion at the pituitary, preventing excessive androgen production. In parallel, inhibin B from Sertoli cells selectively downregulates FSH secretion. This dual-feedback system allows independent control of testosterone production and spermatogenesis, maintaining reproductive function despite physiological stressors, illness, or environmental variation.
Puberty and Hormonal Changes Across the Lifespan
At puberty, increased GnRH pulsatility activates the hypothalamic–pituitary–gonadal axis, leading to rising LH and FSH secretion, testicular enlargement, initiation of spermatogenesis, and development of secondary sexual characteristics. Testosterone levels peak in early adulthood and then decline gradually with age, largely due to reduced Leydig cell responsiveness rather than abrupt endocrine failure.
Exogenous testosterone and anabolic steroid use profoundly disrupt this regulatory system. External androgens suppress GnRH, LH, and FSH secretion through negative feedback, leading to reduced intratesticular testosterone, testicular atrophy, and impaired spermatogenesis. These effects highlight the dependence of sperm production on endogenous hormonal signalling rather than circulating testosterone alone.
Clinical Connections
Disorders affecting the hypothalamic–pituitary–gonadal axis can disrupt testosterone production, spermatogenesis, and sexual development at multiple levels. Because this axis relies on coordinated signalling between the brain and testes, abnormalities may present with infertility, delayed or incomplete puberty, reduced libido, erectile dysfunction, or systemic features of androgen deficiency. Interpreting hormone patterns helps localise the site of dysfunction rather than treating low testosterone as a single entity.
Two broad patterns of hypogonadism are recognised. Primary hypogonadism arises from intrinsic testicular failure, where Leydig and Sertoli cells are unable to respond appropriately to gonadotrophin stimulation. In this setting, luteinising hormone and follicle-stimulating hormone are elevated due to loss of negative feedback, while testosterone levels remain low. Secondary hypogonadism reflects hypothalamic or pituitary dysfunction, leading to inadequate GnRH or gonadotrophin secretion and consequently low testosterone despite structurally normal testes.
Key clinical patterns seen with HPG axis disruption include:
Primary hypogonadism, with high LH and FSH but low testosterone, seen in conditions such as Klinefelter syndrome, testicular torsion, infection, trauma, or gonadotoxic chemotherapy
Secondary hypogonadism, characterised by low or inappropriately normal LH and FSH with low testosterone, due to hypothalamic or pituitary disease
Functional suppression of the axis, from exogenous testosterone, anabolic steroid use, chronic illness, or severe energy deficiency
Fertility can be impaired even when serum testosterone appears normal. Spermatogenesis depends on very high intratesticular testosterone concentrations, which fall rapidly when LH secretion is suppressed. This explains why individuals receiving exogenous testosterone therapy may develop oligospermia or azoospermia despite normal or elevated circulating testosterone levels.
Assessment of male infertility therefore requires more than a single testosterone measurement. Evaluation of LH, FSH, and inhibin B provides insight into Sertoli cell activity and spermatogenic capacity, helping distinguish testicular failure from central suppression.
Concept Check
How does pulsatile GnRH release influence LH and FSH secretion?
What are the distinct roles of FSH and LH in regulating spermatogenesis and testosterone production?
Why are high intratesticular testosterone levels essential for sperm development?
How do inhibin B and testosterone work together to regulate the HPG axis?
What effects does exogenous testosterone have on endogenous hormone production and fertility?